Increased levels of succinate in individuals with inflammatory bowel disease suppress succinylation of the transcription factor FOXP3, leading to its increased ubiquitination and degradation in intestinal regulatory T cells. This process exacerbates colon inflammation and contributes to disease progression.
Insight
is our reward